INTEGRATED BIOPHARMA INC (INBP) Executive Compensation
INTEGRATED BIOPHARMA INC (INBP) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INBP
CIK: 1016504
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 6/30/2025 12:00:00 AM
Lead Engagement PartnerMichael Cohen
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-25 | 2026-09-25 | FORM 8-K | 0001437749-26-031247 | View SEC Doc Filr Page |
| 10-K | 2026-09-25 | 2026-06-30 | FORM 10-K | 0001437749-26-031241 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-20 | FORM 8-K | 0001437749-26-028628 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | FORM 8-K PNC FIRST AMENDMENT | 0001437749-26-022415 | View SEC Doc Filr Page |
| 4/A | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001216280-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001345281-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001216280-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001382218-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001443194-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-08 | FORM 8-K | 0001437749-26-015928 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | FORM 10-Q | 0001437749-26-015899 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-17 | — | SCHEDULE 13D/A Filing | 0001102948-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-17 | — | SCHEDULE 13D Filing | 0001345281-26-000007 | View SEC Doc Filr Page |
| 4/A | 2026-04-17 | 2026-04-15 | PRIMARY DOCUMENT | 0001443194-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-03-24 | PRIMARY DOCUMENT | 0001443194-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-04-15 | PRIMARY DOCUMENT | 0001102948-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-17 | 2026-04-15 | PRIMARY DOCUMENT | 0001345281-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-04-15 | 2026-04-14 | FORM 8-K | 0001437749-26-012368 | View SEC Doc Filr Page |
| 4 | 2026-03-26 | 2026-03-24 | PRIMARY DOCUMENT | 0001102948-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-03-25 | 2026-03-24 | PRIMARY DOCUMENT | 0001443194-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-03-25 | 2026-03-24 | PRIMARY DOCUMENT | 0001345281-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-02-18 | 2026-02-17 | FORM 8-K | 0001437749-26-004553 | View SEC Doc Filr Page |
| 8-K | 2026-02-11 | 2026-02-11 | FORM 8-K | 0001437749-26-003808 | View SEC Doc Filr Page |
| 10-Q | 2026-02-11 | 2025-12-31 | FORM 10-Q | 0001437749-26-003803 | View SEC Doc Filr Page |
| 4 | 2025-12-10 | 2025-12-09 | PRIMARY DOCUMENT | 0001064901-25-000002 | View SEC Doc Filr Page |